Qgenetics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Qgenetics General Information

Description

Developer of biotechnological therapeutics designed to treat osteoporosis and age-related conditions. The company's technology integrates artificial intelligence with medicinal chemistry to control mesenchymal stem cell differentiation, enabling healthcare providers to restore biological rhythms and treat fractures, obesity, and osteoarthritis through oral osteoanabolic drugs and synthetic bone grafts.

Contact Information

Website
www.qgenetics.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 401, Research and Business Development Foundation
  • 26, Kyungheedae-ro, Dongdaemun-gu
  • Seoul
  • South Korea
+82
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Medical Supplies
Vertical(s)
LOHAS & Wellness, Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • Number 401, Research and Business Development Foundation
  • 26, Kyungheedae-ro, Dongdaemun-gu
  • Seoul
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qgenetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Nov-2026 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series B) 01-Apr-2026 Cancelled Clinical Trials - Phase 2
3. Secondary Transaction - Private Completed Clinical Trials - Phase 1
2. Seed Round 11-Apr-2021 $2.66M $2.66M Completed Clinical Trials - Phase 1
1. Accelerator/Incubator Completed Clinical Trials - Phase 1
To view Qgenetics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Qgenetics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qgenetics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
KGROUND Ventures Venture Capital Minority
LSK Investment Venture Capital Minority
Magna Investment (Seoul) Venture Capital Minority
Seoul Biohub Accelerator/Incubator
To view Qgenetics’s complete investors history, request access »

Ready to get started?

Request a free trial

Qgenetics FAQs

  • When was Qgenetics founded?

    Qgenetics was founded in 2016.

  • Where is Qgenetics headquartered?

    Qgenetics is headquartered in Seoul, South Korea.

  • What is the size of Qgenetics?

    Qgenetics has 11 total employees.

  • What industry is Qgenetics in?

    Qgenetics’s primary industry is Biotechnology.

  • Is Qgenetics a private or public company?

    Qgenetics is a Private company.

  • What is Qgenetics’s current revenue?

    The current revenue for Qgenetics is .

  • How much funding has Qgenetics raised over time?

    Qgenetics has raised $2.66M.

  • Who are Qgenetics’s investors?

    KGROUND Ventures, LSK Investment, Magna Investment (Seoul), and Seoul Biohub have invested in Qgenetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process